Cargando…

Immune checkpoint inhibitor‐related molecular markers predict prognosis in extrahepatic cholangiocarcinoma

BACKGROUND: Therapeutic approaches for extrahepatic cholangiocarcinoma (EHCC) are limited, due to insufficient understanding to biomarkers related to prognosis and drug response. Here, we comprehensively assess the molecular characterization of EHCC with clinical implications. METHODS: Whole‐exome s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jin, Bao, Wang, Yuxin, Zhang, Baoluhe, Xu, Haifeng, Lu, Xin, Sang, Xinting, Wang, Wenze, Mao, Yilei, Chen, Pengxiao, Wang, Shun, Qian, Zhirong, Wang, Yingyi, Du, Shunda
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10652350/ https://www.ncbi.nlm.nih.gov/pubmed/37814942 http://dx.doi.org/10.1002/cam4.6441

Ejemplares similares

Preoperative Bilirubin-Adjusted Carbohydrate Antigen 19-9 as a Prognostic Factor for Extrahepatic Cholangiocarcinoma Patients at a Single Center
por: Li, Jiayi, et al.
Publicado: (2020)

In situ Detecting Lipids as Potential Biomarkers for the Diagnosis and Prognosis of Intrahepatic Cholangiocarcinoma
por: Li, Jiayi, et al.
Publicado: (2022)

Prognostic Nomogram That Predicts Overall Survival of Patients with Distal Cholangiocarcinoma After Pancreatoduodenectomy
por: Chen, Qiao, et al.
Publicado: (2020)

The Prognostic Value of Systemic Inflammation Response Index in Cholangiocarcinoma Patients
por: Jin, Bao, et al.
Publicado: (2021)

Novel Drug Candidate Prediction for Intrahepatic Cholangiocarcinoma via Hub Gene Network Analysis and Connectivity Mapping
por: Xiao, Yao, et al.
Publicado: (2022)

Differential Diagnosis of Immunoglobulin G4-associated Cholangitis From Cholangiocarcinoma
por: Du, Shunda, et al.
Publicado: (2016)

Laparoscopic hepatectomy for patients who received enterostomy
por: Jin, Bao, et al.
Publicado: (2019)

Aggressive Locoregional Treatment Improves the Outcome of Liver Metastases from Grade 3 Gastroenteropancreatic Neuroendocrine Tumors
por: Du, Shunda, et al.
Publicado: (2015)

Exploring the function of stromal cells in cholangiocarcinoma by three-dimensional bioprinting immune microenvironment model
por: Li, Changcan, et al.
Publicado: (2022)

Surgical Resection Improves the Outcome of the Patients With Neuroendocrine Tumor Liver Metastases: Large Data From Asia
por: Du, Shunda, et al.
Publicado: (2015)

Diagnosis and treatment of a diaphragmatic pheochromocytoma: A case report
por: Wu, Xiangan, et al.
Publicado: (2020)

Current trends and research topics regarding liver 3D bioprinting: A bibliometric analysis research
por: Jin, Bao, et al.
Publicado: (2022)

Comment on Liver Venous Deprivation or Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy?: A Retrospective Multicentric Study
por: Xing, Jiali, et al.
Publicado: (2022)

Novel insights into the intraepithelial spread of extrahepatic cholangiocarcinoma: clinicopathological study of 382 cases on extrahepatic cholangiocarcinoma
por: Nagashima, Daisuke, et al.
Publicado: (2023)

Emerging Role of microRNA Dysregulation in Diagnosis and Prognosis of Extrahepatic Cholangiocarcinoma
por: Prinz, Christian, et al.
Publicado: (2022)

The Significance of Adjuvant Therapy for Extrahepatic Cholangiocarcinoma After Surgery
por: Wang, Gaoyuan, et al.
Publicado: (2019)

Comparison of the clinical results of surgical resection for extrahepatic cholangiocarcinomas: Hilar cholangiocarcinoma and mid-to-distal cholangiocarcinoma
por: Jung, Pyung, et al.
Publicado: (2019)

Expression of FOXP1 and FOXO3a in extrahepatic cholangiocarcinoma and the implications in clinicopathological significance and prognosis
por: He, Jun, et al.
Publicado: (2019)

The Clinicopathological and Prognostic Value of PD-L1 Expression in Cholangiocarcinoma: A Meta-Analysis
por: Xu, Gang, et al.
Publicado: (2019)

PD-L1 and PD-1 expression correlate with prognosis in extrahepatic cholangiocarcinoma
por: Ma, Ke, et al.
Publicado: (2017)

Single-cell landscape of immunocytes in patients with extrahepatic cholangiocarcinoma
por: Xu, Lei, et al.
Publicado: (2022)

Controlling nutritional status score as a prognostic marker to predict overall survival in resected biliary tract cancers
por: Sun, Lejia, et al.
Publicado: (2021)

Confinement to the intrapancreatic bile duct is independently associated with a better prognosis in extrahepatic cholangiocarcinoma
por: Ahn, Keun Soo, et al.
Publicado: (2016)

Overexpression of 14-3-3δ Predicts Poor Prognosis in Extrahepatic Cholangiocarcinoma Patients
por: Wu, Qiao, et al.
Publicado: (2020)

Role of Endoscopic Ultrasonography in the Evaluation of Extrahepatic Cholangiocarcinoma
por: Strongin, Anna, et al.
Publicado: (2013)

Dose escalation of radiotherapy in unresectable extrahepatic cholangiocarcinoma
por: Elganainy, Dalia, et al.
Publicado: (2018)

Characterization of biliary microbiota dysbiosis in extrahepatic cholangiocarcinoma
por: Saab, Massa, et al.
Publicado: (2021)

An overview of extrahepatic cholangiocarcinoma: from here to where?
por: Yang, Yongheng, et al.
Publicado: (2023)

Influence of marital status on the survival of adults with extrahepatic/intrahepatic cholangiocarcinoma
por: Chen, Zhiqiang, et al.
Publicado: (2017)

Serum mucin 3A as a potential biomarker for extrahepatic cholangiocarcinoma
por: Wang, Jing, et al.
Publicado: (2020)

Increased expression of cystathionine beta-synthase and chemokine ligand 21 is closely associated with poor prognosis in extrahepatic cholangiocarcinoma
por: Wang, Lingxiang, et al.
Publicado: (2020)

Clinical features and survival outcome of locally advanced extrahepatic cholangiocarcinoma
por: Lee, Sang-Jae, et al.
Publicado: (2014)

The E-cadherin repressor slug and progression of human extrahepatic hilar cholangiocarcinoma
por: Zhang, Ke-jun, et al.
Publicado: (2010)

Does high-grade dysplasia/carcinoma in situ of the biliary duct margin affect the prognosis of extrahepatic cholangiocarcinoma? A meta-analysis
por: Ke, Qiao, et al.
Publicado: (2019)

Geographic Variation of Intrahepatic Cholangiocarcinoma, Extrahepatic Cholangiocarcinoma, and Hepatocellular Carcinoma in the United States
por: Altekruse, Sean F., et al.
Publicado: (2015)

Clinicopathologic and prognostic significance of regulatory T cells in patients with hepatocellular carcinoma: a meta-analysis
por: Sun, Lejia, et al.
Publicado: (2017)

Comprehensive analysis of coagulation indices for predicting survival in patients with biliary tract cancer
por: Ke, Xindi, et al.
Publicado: (2021)

Whole-exome sequencing reveals the origin and evolution of hepato-cholangiocarcinoma
por: Wang, Anqiang, et al.
Publicado: (2018)

An inguinal hernia sac tumor of extrahepatic cholangiocarcinoma origin
por: Yokoyama, Naoyuki, et al.
Publicado: (2006)

Gallstones and cholecystectomy in relation to risk of intra- and extrahepatic cholangiocarcinoma
por: Nordenstedt, H, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_bp11tvcftml2q5lc96ctav092q